Moderna, Inc. (MRNA) Options Statistics & Positioning

Moderna, Inc. (MRNA) options trade at a 30-day at-the-money implied volatility of 92.5%, an IV rank of 81 out of 100 over the past year. The options market prices a ±$33.83 (±24.2%) move in MRNA for the front expiration. Max pain sits at $95 and the put/call open interest ratio is 1.60. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.

Data as of Aug 24, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close

$139.74

52-week range

$22.35 – $174.64

ATM IV (30d)

92.5%

IV rank

81 / 100

High

Expected move

±$33.83 (±24.2%)

Put/call OI

1.60

Put-heavy

Max pain

$95

↓ 32.0% below close

Next earnings

Nov 4, 2026

Most Active MRNA Contracts

Contract	Expiration	DTE	Last	IV	Volume
MRNA $180 call	Aug 28, 2026	3d	$1.99	146.2%	17,372
MRNA $160 call	Aug 28, 2026	3d	$7.15	139.9%	15,126
MRNA $200 call	Aug 28, 2026	3d	$0.67	165.1%	11,235
MRNA $180 call	Sep 18, 2026	24d	$8.30	96.1%	9,742
MRNA $170 call	Aug 28, 2026	3d	$3.70	142.8%	8,013

See all active MRNA contracts →

Explore MRNA Options Statistics

MRNA Implied Volatility

92.5% ATM IV (30d)

An IV rank of 81 places implied volatility near the top of its 52-week range.

Full implied volatility analysis →

MRNA Open Interest

1.60 put/call OI ratio

316,040 calls and 506,102 puts outstanding across all expirations.

Full open interest analysis →

MRNA Max Pain

$95 max pain

32.0% below the last close — see how max pain has moved over the past year.

Full max pain analysis →

MRNA Gamma Exposure

$658.36M net GEX

Positive dealer gamma — hedging currently leans against price swings.

Full gamma exposure analysis →

MRNA Options Volume

184,621 contracts traded

Put/call volume ratio 1.15 — plus contracts running far above their usual volume.

Full volume & flow analysis →

MRNA Most Active Options

$130 top volume strike

The 25 most actively traded MRNA contracts with price, IV, greeks, and volume vs. average.

Full active contracts analysis →

Upcoming Earnings

MRNA's next expected earnings date is Nov 4, 2026. Options currently price a ±$33.83 (±24.2%) move for the front expiration.

Explore the payoff profile of option on MRNA for free

Build multi-leg MRNA strategies, visualize payoffs, and scan the full US options universe with OptiView.

Open MRNA in the platform Scan options

MRNA Options FAQ

When is MRNA's next earnings date?

MRNA's next expected earnings date is Nov 4, 2026. Options currently price a ±$33.83 (±24.2%) move for the front expiration.

How often is MRNA options data on this page updated?

All MRNA statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.

Where can I see MRNA max pain, open interest, and implied volatility in detail?

OptiView publishes dedicated MRNA pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.